Creative Biolabs provides research-use phage purification with PEG precipitation to support phage concentration, partial cleanup, pellet recovery, and downstream compatibility planning. We position PEG precipitation accurately: it is mainly a concentration and partial purification step, not a complete high-purity purification method for all phage preparations.
PEG precipitation is widely used because it can concentrate phage particles from larger liquid volumes using PEG and salt under controlled temperature and incubation conditions. At the same time, PEG can co-precipitate host proteins, nucleic acids, debris, or other matrix components. Our service therefore focuses on condition selection, recovery review, resuspension quality, and recommendations for SEC, CsCl, dialysis, or other follow-up cleanup when higher purity is required.
Researchers usually request PEG precipitation when they need to concentrate phage particles from lysate or conditioned medium before characterization, storage, or additional purification. It is also useful as an early handling step when the priority is volume reduction rather than final analytical purity.
Reduce sample volume before downstream titering, sequencing support, or additional purification.
Compare practical concentration factor with phage activity and resuspension quality.
Remove some soluble background while acknowledging possible co-precipitated material.
Decide whether SEC, CsCl, dialysis, or buffer exchange should follow PEG recovery.
The PEG strategy is designed around the starting lysate, desired concentration factor, phage sensitivity, and downstream use. We can evaluate solid PEG addition or PEG solution such as 50% PEG, salt concentration, PEG molecular weight, ionic strength, pH, temperature, precipitation time, centrifugation conditions, and resuspension buffer.
For many projects, low-temperature incubation, including overnight precipitation at 4°C, can be considered. The final design depends on sample volume, target recovery, and whether residual PEG or co-precipitated host material may interfere with downstream assays. We also retain practical original-page considerations such as propagation, lysate preparation, PEG optimization, and phage detection after recovery.
Starting titer, volume, clarity, and buffer constraints are reviewed.
Debris and cells are reduced before precipitation when needed.
PEG and salt conditions are selected for the target concentration goal.
Samples are incubated under controlled temperature and time conditions.
The pellet is recovered and resuspended with attention to completeness.
Titer, recovery, clarity, and downstream compatibility are summarized.
| Input Type | Useful Details |
|---|---|
| Phage Material | Phage lysate or stock, starting volume and titer, phage type, and host background. |
| Concentration Goal | Desired concentration factor, final volume, and acceptable loss range if known. |
| Compatibility Limits | Buffer constraints, downstream assay requirements, and tolerance for residual PEG or impurities. |
Creative Biolabs can help decide whether PEG precipitation is sufficient for the next step or should be paired with polishing or buffer exchange.
PEG condition, incubation, centrifugation, and resuspension notes.
Titer or recovery estimate when included in the project scope.
Comments on residual PEG, salt, turbidity, or possible co-precipitated material.
Guidance on SEC, CsCl, dialysis, or other cleanup when higher purity is needed.
Quality checkpoints include lysate clarity, PEG and salt concentration traceability, temperature and incubation control, centrifugation settings, pellet recovery, resuspension completeness, titer retention, and visible turbidity review. We also flag limitations related to co-precipitated host material or residual PEG.
The workflow can be customized around PEG molecular weight and concentration, salt level, pH, temperature, incubation duration, centrifugation conditions, resuspension buffer, optional secondary cleanup, and downstream compatibility checks. We recommend setting these variables before project start, especially when the recovered phage will be used in activity-sensitive assays.
The same 2021 Viruses study compared standard phage purification procedures, including PEG precipitation with different PEG molecular weights and CsCl density gradients, using individual and mixed bacteriophage samples. The authors measured phage number and activity throughout the workflow and reported that routine procedures can cause measurable losses, with effects varying by phage structure, sample composition, and purification condition. For PEG precipitation, the study explained that PEG is often used for bulk concentration, yet it may co-precipitate host-derived material and does not replace downstream polishing when higher purity is required. In research-service planning, this supports treating PEG precipitation as a concentration and partial cleanup step, followed by recovery review and optional compatibility checks for residual PEG, salt, or co-precipitated impurities.
This literature discussion is included as method background only. It does not represent a guarantee of sample recovery, activity, purity, host-range behavior, or project outcome in a client-specific study.
Fig.1 Reduction in phage nucleic acid signal after PEG precipitation and CsCl gradient purification.1
Q: What information is needed to start a PEG precipitation project?
A: We usually need the phage lysate or stock, starting volume and titer, phage type if known, desired concentration factor, buffer constraints, and downstream use.
Q: Is PEG precipitation a complete purification method?
A: No. PEG precipitation is mainly a concentration and partial cleanup step. It may leave residual PEG or co-precipitated host material, so additional polishing may be needed.
Q: Can the PEG workflow be customized?
A: Yes. We can adjust PEG molecular weight, PEG concentration, salt level, temperature, incubation duration, centrifugation conditions, resuspension buffer, and optional follow-up cleanup.
Q: What deliverables are included?
A: Typical deliverables include the concentration workflow summary, pre/post titer or recovery estimate when included, resuspension notes, compatibility comments, and next-step cleanup recommendations.
Q: How are quality checks handled?
A: We track lysate clarity, PEG/salt conditions, incubation temperature, pellet recovery, resuspension completeness, titer retention, and possible impurity carryover.
Q: How can I discuss a nonstandard PEG project?
A: Send the sample volume, titer, phage type, target final volume, buffer needs, and downstream assay. We will help define a practical concentration and cleanup plan.
Ready to plan the next experiment? Send us the material status, project goal, and required reporting depth. We will help define a research-use workflow that fits your study design.
Reference:
Please kindly note that our services can only be used to support research purposes (Not for clinical use).
Creative Biolabs is a globally recognized phage company. Creative Biolabs is committed to providing researchers with the most reliable service and the most competitive price.
